Cutaneous leishmaniasis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Desjeux, 2001, The increase in risk factors for leishmaniasis worldwide, Trans R Soc Trop Med Hyg, 95, 239, 10.1016/S0035-9203(01)90223-8
Reyburn, 2003, The prolonged epidemic of anthroponotic cutaneous leishmaniasis in Kabul, Afghanistan: ‘bringing down the neighbourhood’, Trans R Soc Trop Med Hyg, 97, 170, 10.1016/S0035-9203(03)90111-8
Bailey MS, Caddy AJ, McKinnon KA, et al. Zoonotic cutaneous leishmaniasis with local dissemination in Afghanistan. 2007 [in press].
Weina, 2004, Old world leishmaniasis: an emerging infection among deployed US military and civilian workers, Clin Infect Dis, 39, 1674, 10.1086/425747
Sanchez, 1992, Epidemiologic investigation of an outbreak of cutaneous leishmaniasis in a defined geographic focus of transmission, Am J Trop Med Hyg, 47, 47, 10.4269/ajtmh.1992.47.47
Reithinger, 2005, Social impact of leishmaniasis, Afghanistan, Emerg Infect Dis, 11, 634, 10.3201/eid1104.040945
Reithinger, 2005, Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, control trial, Clin Infect Dis, 40, 1148, 10.1086/428736
Gradoni, 1994, Leishmania infantum tropism: strain genotype or host immune status?, Parasitol Today, 10, 264, 10.1016/0169-4758(94)90142-2
Karunaweera, 2003, Sri Lankan cutaneous leishmaniasis is caused by Leishmania donovani zymodeme MON-37, Trans R Soc Trop Med Hyg, 97, 380, 10.1016/S0035-9203(03)90061-7
Noyes, 1997, Leishmania chagasi: genotypically similar parasites from Honduras cause both visceral and cutaneous leishmaniasis in humans, Exp Parasitol, 85, 264, 10.1006/expr.1996.4133
Zijlstra, 2003, Post–kala-azar dermal leishmaniasis, Lancet Infect Dis, 3, 87, 10.1016/S1473-3099(03)00517-6
Mehregan, 1999, Histological diagnosis of cutaneous leishmaniasis, Clin Dermatol, 17, 297, 10.1016/S0738-081X(99)00048-6
Ghersetich, 1999, Immune response to Leishmania infection in human skin, Clin Dermatol, 17, 333, 10.1016/S0738-081X(99)00053-X
Kubba, 1988, Dissemination in cutaneous leishmaniasis. II. Satellite papules and subcutaneous induration, Int J Dermatol, 27, 702, 10.1111/j.1365-4362.1988.tb01268.x
Gaafar, 1994, Sporotrichoid cutaneous leishmaniasis due to Leishmania major of different zymodemes in the Sudan and Saudi Arabia: a comparative study, Trans R Soc Trop Med Hyg, 88, 552, 10.1016/0035-9203(94)90158-9
Wortmann, 2000, Cutaneous leishmaniasis following local trauma: a clinical pearl, Clin Infect Dis, 31, 199, 10.1086/313924
Al-Qurashi, 2000, Dissemination in cutaneous leishmaniasis due to Leishmania major in different ethnic groups in Saudi Arabia, Int J Dermatol, 39, 832, 10.1046/j.1365-4362.2000.00059.x
Turetz, 2002, Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil, J Infect Dis, 186, 1829, 10.1086/345772
Schraner, 2005, Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1, Clin Infect Dis, 40, e120, 10.1086/430444
Silveira, 2004, Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil—a review, Mem Inst Oswaldo Cruz, 99, 239, 10.1590/S0074-02762004000300001
Ahluwalia, 2004, Mucocutaneous leishmaniasis: an imported infection among travellers to central and South America, BMJ, 329, 842, 10.1136/bmj.329.7470.842
Lawn, 2004, New world mucosal and cutaneous leishmaniasis: an emerging health problem among British travellers, QJM, 97, 781, 10.1093/qjmed/hch127
Couppie, 2004, Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)–infected patients and non–HIV-infected patients in French Guiana, Br J Dermatol, 151, 1165, 10.1111/j.1365-2133.2004.06226.x
Pintado, 2001, HIV-associated visceral leishmaniasis, Clin Microbiol Infect, 7, 291, 10.1046/j.1198-743x.2001.00262.x
Motta, 2003, Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid, Int J Dermatol, 42, 703, 10.1046/j.1365-4362.2003.01730.x
Gontijo, 2002, Concurrent cutaneous, visceral and ocular leishmaniasis caused by Leishmania (Viannia) braziliensis in a kidney transplant patient, Mem Inst Oswaldo Cruz, 97, 751, 10.1590/S0074-02762002000500029
Ben Salah, 1995, A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment, Am J Trop Med Hyg, 53, 162, 10.4269/ajtmh.1995.53.162
Asilian, 1995, A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for the treatment of cutaneous leishmaniasis in Iran, Am J Trop Med Hyg, 53, 648, 10.4269/ajtmh.1995.53.648
Dowlati, 1996, Cutaneous leishmaniasis: clinical aspects, Clin Dermatol, 14, 425, 10.1016/0738-081X(96)00058-2
Herwaldt, 1992, The natural history of cutaneous leishmaniasis in Guatemala, J Infect Dis, 165, 518, 10.1093/infdis/165.3.518
Teklemariam, 1994, Aminosidine and its combination with sodium stibogluconate in the treatment of diffuse cutaneous leishmaniasis caused by Leishmania aethiopica, Trans R Soc Trop Med Hyg, 88, 334, 10.1016/0035-9203(94)90106-6
Siriwardena, 2003, Clinical features, risk factors and efficacy of cryotherapy in cutaneous leishmaniasis in Sri Lanka, Ceylon Med J, 48, 10, 10.4038/cmj.v48i1.3386
Ben Said, 2006, Occurrence of Leishmania infantum cutaneous leishmaniasis in central Tunisia, Trans R Soc Trop Med Hyg, 100, 521, 10.1016/j.trstmh.2005.08.012
Ponce, 1991, Leishmania donovani chagasi: new clinical variant of cutaneous leishmaniasis in Honduras, Lancet, 337, 67, 10.1016/0140-6736(91)90734-7
Belli, 1999, Widespread atypical cutaneous Leishmaniasis caused by Leishmania (L.) chagasi in Nicaragua, Am J Trop Med Hyg, 61, 380, 10.4269/ajtmh.1999.61.380
Magill, 2005, Cutaneous leishmaniasis in the returning traveler, Infect Dis Clin North Am, 19, 241, 10.1016/j.idc.2004.11.005
Bailey, 2005, Clinical guidelines for the management of cutaneous leishmaniasis in British military personnel, J R Army Med Corps, 151, 73, 10.1136/jramc-151-02-03
Ramirez, 2000, Diagnosis of cutaneous leishmaniasis in Colombia: the sampling site within lesions influences the sensitivity of parasitologic diagnosis, J Clin Microbiol, 38, 3768, 10.1128/JCM.38.10.3768-3773.2000
Dar, 2005, Comparison of skin smears and biopsy specimens for demonstration of Leishmania tropica bodies in cutaneous leishmaniasis, J Coll Physicians Surg Pak, 15, 765
Laskay, 1995, Detection of cutaneous Leishmania infection in paraffin-embedded skin biopsies using the polymerase chain reaction, Trans R Soc Trop Med Hyg, 89, 273, 10.1016/0035-9203(95)90537-5
Bensoussan, 2006, Comparison of PCR assays for diagnosis of cutaneous leishmaniasis, J Clin Microbiol, 44, 1435, 10.1128/JCM.44.4.1435-1439.2006
Wortmann, 2005, Rapid identification of Leishmania complexes by a real-time PCR assay, Am J Trop Med Hyg, 73, 999, 10.4269/ajtmh.2005.73.999
Allahverdiyev, 2004, A sensitive new microculture method for diagnosis of cutaneous leishmaniasis, Am J Trop Med Hyg, 70, 294, 10.4269/ajtmh.2004.70.294
Chargui, 2005, Usefulness of PCR in the diagnosis of cutaneous leishmaniasis in Tunisia, Trans R Soc Trop Med Hyg, 99, 762, 10.1016/j.trstmh.2005.06.002
Ihalamulla, 2006, Microculture for the isolation of Leishmania, modified to increase efficacy: a follow-up to a previous study, Ann Trop Med Parasitol, 100, 87, 10.1179/atm.2006.100.1.87
Al-Jaser, 2005, Treatment trends of cutaneous leishmaniasis in Saudi Arabia, Saudi Med J, 26, 1220
Blum, 2004, Treatment of cutaneous leishmaniasis among travellers, J Antimicrob Chemother, 53, 158, 10.1093/jac/dkh058
Arana, 2001, Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala, Am J Trop Med Hyg, 65, 466, 10.4269/ajtmh.2001.65.466
Armijos, 2004, Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis, Acta Trop, 91, 153, 10.1016/j.actatropica.2004.03.009
Faghihi, 2003, Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate, Clin Exp Dermatol, 28, 13, 10.1046/j.1365-2230.2003.01169.x
Iraji, 2005, Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran Ann Trop Med Parasitol, 99, 3, 10.1179/136485905X16372
Soto, 2002, Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study, Am J Trop Med Hyg, 66, 147, 10.4269/ajtmh.2002.66.147
Mujtaba, 1999, Weekly vs. fortnightly intralesional meglumine antimoniate in cutaneous leishmaniasis, Int J Dermatol, 38, 607, 10.1046/j.1365-4362.1999.00769.x
Asilian, 2004, Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis, Int J Dermatol, 43, 281, 10.1111/j.1365-4632.2004.02002.x
Alrajhi, 2002, Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major, N Engl J Med, 346, 891, 10.1056/NEJMoa011882
Morizot, 2007, Healing of Old World Cutaneous Leishmanasis in travellers treated with fluconazole: Drug effect or spontaneous evolution?, Am J Trop Med Hyg, 76, 48, 10.4269/ajtmh.2007.76.48
Willard, 2005, Cutaneous leishmaniasis in soldiers from Fort Campbell, Kentucky returning from Operation Iraqi Freedom highlights diagnostic and therapeutic options, J Am Acad Dermatol, 52, 977, 10.1016/j.jaad.2005.01.109
Saenz, 1990, Efficacy of ketoconazole against Leishmania braziliensis and panamensis cutaneous leishmaniasis, Am J Med, 89, 147, 10.1016/0002-9343(90)90292-L
Navin, 1992, Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala, J Infect Dis, 165, 528, 10.1093/infdis/165.3.528
Salmanpour, 2001, Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis, J Dermatolog Treat, 12, 159, 10.1080/09546630152607899
Momeni, 1996, Treatment of cutaneous leishmaniasis with itraconazole: randomised double-blind study, Arch Dermatol, 132, 784, 10.1001/archderm.132.7.784
Nassiri-Kashani, 2005, A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis, J Eur Acad Dermatol Venereol, 19, 80, 10.1111/j.1468-3083.2004.01133.x
Soto-Mancipe, 1993, Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia, Clin Infect Dis, 16, 417, 10.1093/clind/16.3.417
Soto, 2004, Miltefosine for new world cutaneous leishmaniasis, Clin Infect Dis, 38, 1266, 10.1086/383321
Herwaldt, 1992, Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies, Am J Trop Med Hyg, 46, 296, 10.4269/ajtmh.1992.46.296
Aronson, 1998, Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent US military experience, Clin Infect Dis, 27, 1457, 10.1086/515027
Wortmann, 2002, A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel, Clin Infect Dis, 35, 261, 10.1086/341406
Medicines and Healthcare products Regulatory Agency. Drug Alert – Pentostam Injection.MDR 47-03/66 dated 11 April 2006.
Croft, 2006, Drug resistance in leishmaniasis, Clin Microbiol Rev, 19, 111, 10.1128/CMR.19.1.111-126.2006
Roussel, 2006, Comparison between one and two injections of pentamidine isethionate, at 7 mg/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana, Ann Trop Med Parasitol, 100, 307, 10.1179/136485906X105561
Seaton, 1999, Out-patient parenteral antimicrobial therapy—a viable option for the management of cutaneous leishmaniasis, Q J Med, 92, 659, 10.1093/qjmed/92.11.659
Lawn, 2006, Electrocardiographic and biochemical adverse effects of sodium stibogluconate during treatment of cutaneous and mucosal leishmaniasis among returned travellers, Trans R Soc Trop Med Hyg, 100, 264, 10.1016/j.trstmh.2005.03.012
Lightburn, 2003, Management of American cutaneous leishmaniasis: outcome of 326 cases treated with high-dose pentamidine isethionate, Med Trop (Mars), 63, 35
Andersen, 2005, Comparison of meglumine antimoniate and pentamidine for Peruvian cutaneous leishmaniasis, Am J Trop Med Hyg, 72, 133, 10.4269/ajtmh.2005.72.133
Brown, 2005, Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis, Br J Dermatol, 153, 203, 10.1111/j.1365-2133.2005.06670.x
Wortmann, 1998, Failure of amphotericin B lipid complex in the treatment of cutaneous leishmaniasis, Clin Infect Dis, 26, 1006, 10.1086/517634
Requena, 2004, Recent advances in vaccines for leishmaniasis, Expert Opin Biol Ther, 4, 1505, 10.1517/14712598.4.9.1505